Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1811-1815

  Fu, Yu ^a   Wei, Xufu ^a   Tang, Chengyong ^a   Li, Jianping ^b   Liu, Rui ^a   Shen, Ai ^a   Wu, Zhongjun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

HBV related HCC; miR 101; Monitor; Serum

Indexed keywords

MICRORNA 101;

ADULT; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IMMUNE DYSREGULATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TUMOR VOLUME;

EID: 84886802057     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1638     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Arbuthnot P and Kew M: Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 82: 77-100, 2001.
3. Oka H, Tamori A, Kuroki T, Kobayashi K and Yamamoto S: Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 19: 61-66, 1994.
4. Marrero JA and Lok AS: Newer markers for hepatocellular carcinoma. Gastroenterology 127: S113-S119, 2004.
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
7. Kloosterman WP and Plasterk RH: The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450, 2006.
8. Stefani G and Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 9: 219-230, 2008.
9. Mott JL: MicroRNAs involved in tumor suppressor and oncogene pathways: implications for hepatobiliary neoplasia. Hepatology 50: 630-637, 2009.
10. Visone R, Petrocca F and Croce CM: Micro-RNAs in gastrointestinal and liver disease. Gastroenterology 135: 1866-1869, 2008.
11. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14: 419-427, 2008.
12. Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, et al: miR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 27: 5651-5661, 2008.
13. Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, et al: MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 12: 2189-2204, 2008.
14. Cortez MA and Calin GA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9: 703-711, 2009.
15. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
16. Zhu W, Qin W, Atasoy U and Sauter ER: Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2: 89, 2009.
17. Pain SJ, Barber RW, Ballinger JR, Solanki CK, Mortimer PS, Purushotham AD and Peters AM: Local vascular access of radioprotein injected subcutaneously in healthy subjects and patients with breast cancer-related lymphedema. J Nucl Med 45: 789-796, 2004.
18. Croci S, Pedrazzi G, Passeri G, Delsignore R and Ortalli I: Red cell Hb oxidation of healthy subjects compared to breast cancer patients. Anticancer Res 22: 2903-2906, 2002.
19. Würz H, Lüben G and Bohn H: Serum levels of placental protein 10 (PP10) in women with breast cancer and genital carcinoma and in healthy male and female subjects. Arch Gynecol 233: 267-274, 1983.
20. Wei X, Xiang T, Ren G, Tan C, Liu R, Xu X and Wu Z: miR-101 is down-regulated by the hepatitis B virus x protein and induces aberrant DNA methylation by targeting DNA methyltransferase 3A. Cell Signal 25: 439-446, 2013.
21. Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, et al: Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res 14: 470-477, 2008.
22. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al: The microRNA spectrum in 12 body fluids. Clin Chem 56: 1733-1741, 2010.
23. Ng EK, Chong WW, Jin H, Lam EK, Shin VY, Yu J, et al: Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58: 1375-1381, 2009.
24. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N: Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55: 1944-1949, 2009.
25. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, et al: Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106: 4402-4407, 2009.
26. Bianchi F, Nicassio F, Marzi M, Belloni E, Dall'olio V, Bernard L, et al: A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol Med 3: 495-503, 2011.
27. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, et al: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963, 2008.
28. Liu S, Guo W, Shi J, Li N, Yu X, Xue J, et al: MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 56: 389-396, 2012.
29. Qi P, Cheng SQ, Wang H, Li N, Chen YF and Gao CF: Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One 6: e28486, 2011.
30. Brase JC, Wuttig D, Kuner R and Sültmann H: Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9: 306, doi: 10.1186/1476-4598-9-306, 2010.
31. Wittmann J and Jäck HM: Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806: 200-207, 2010.
32. Jackson DB: Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci USA 106: E5, 2009.
33. Qu KZ, Zhang K, Li H, Afdhal NH and Albitar M: Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol 45: 355-360, 2011.
34. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476, 2008.
35. Cortez MA and Calin GA: MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther 9: 703-711, 2009.
36. Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, de Gruijl TD, et al: Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci USA 107: 6328-6333, 2010.